跳至主要内容
临床试验/NCT03196557
NCT03196557已完成1 期

An Experimental Medicine Study to Assess the Pharmacodynamics Following Administration of Multiple Doses of Prednisolone to Healthy Male Subjects

Bristol-Myers Squibb2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2008年3月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
24
试验地点
2
主要终点
Interleukin 1 beta

研究概览

简要总结

The purpose of this study is to assess the pharmacodynamics of Prednisolone in healthy male subjects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
  • Body Mass Index (BMI) of 18 to 30 kilogram / square meter (kg/m2), inclusive
  • Signed informed consent

排除标准

  • Any significant acute or chronic medical illness
  • Current or recent (within 3 months) gastrointestinal disease including peptic ulcer
  • Other protocol inclusion/exclusion criteria may apply

研究组 & 干预措施

Arm A

Experimental

Specified dose on specified days

干预措施: Prenisolone (Drug)

Arm B

Placebo Comparator

Specified dose on specified days

干预措施: Placebo (Drug)

结局指标

主要结局

Interleukin 1 beta

时间窗: Up to 32 days

As measured by flow cytometry

Cell Populations

时间窗: Up to 32 days

As measured by flow cytometry

Tumor necrosis factor-alpha

时间窗: Up to 32 days

As measured by flow cytometry

Receptor activator of nuclear factor-kB (RANK)

时间窗: Up to 32 days

As measured by flow cytometry

Receptor activator of nuclear factor-kB ligand (RANKL)

时间窗: Up to 32 days

As measured by flow cytometry

Osteoprotegrin (OPG)

时间窗: Up to 32 days

As measured by flow cytometry

Bone-specific alkaline phosphatase

时间窗: Up to 32 days

As measured by blood concentration

Calcium

时间窗: Up to 32 days

As measured by urine concentration

Oral glucose tolerance test

时间窗: Up to 32 days

Assessed by central labortatory

Cortisol

时间窗: Up to 32 days

As measured by the level of the hormone cortisol in the blood

Adrenocorticotropic hormone

时间窗: Up to 32 days

As measured by the level of the hormone in the blood

Osteocalcin

时间窗: Up to 32 days

As measured by blood concentration

Lipopolysaccharide Induced Cytokine Production

时间窗: Up to 32 days

As measured by blood concentration

N-terminal Pro-Collagen Peptide (PINP)

时间窗: Up to 32 days

As measured by blood concentration

Propetide type I C-term Pro-collagen Peptide (CICP)

时间窗: Up to 32 days

As measured by blood concentration

Urinary deoxypyridinoline

时间窗: Up to 32 days

As measured by urine concentration

C Telopeptide of Collagen Type II (CTX-II)

时间窗: Up to 32 days

As measured by urine concentration

Creatinine

时间窗: Up to 32 days

As measured by urine concentration

次要结局

未报告次要终点

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验